2017;153:S65 71. 4. Takagi H, Hari Y, Kawai N, et al. Meta-analysis of transcatheter aortic valve implantation for bicuspid versus tricuspid aortic valves. J Cardiol. 2019;74:40 8. 5. Kanjanahattakij N, Horn B, Vutthikraivit W, et al. Comparing outcomes after transcatheter aortic valve replacement in patients with stenotic bi- cuspid and tricuspid aortic valve: a systematic review and meta-analysis. Clin Cardiol. 2018;41:896 902. 6. Makkar RR, Yoon S-H, Leon MB, et al. Association between transcatheter aortic valve replacement for bicuspid vs tricuspid aortic stenosis and mor- tality or stroke. JAMA. 2019;321:2193 202. 7. Beckerman Z, Kayatta MO, McPherson L, et al. Bicuspid aortic valve repair in the setting of severe aortic insufficiency. J Vis Surg. 2018;4:101. 6. MITRAL STENOSIS 1. Eleid MF, Nishimura RA, Lennon RJ, et al. Left ventricular diastolic dys- function in patients with mitral stenosis undergoing percutaneous mitral balloon valvotomy. Mayo Clin Proc. 2013;88:337 44. CLINICAL STATEMENTS AND GUIDELINES 2. Nunes MCP, Tan TC, Elmariah S, et al. Net atrioventricular compliance is an independent predictor of cardiovascular death in mitral stenosis. Heart. 2017;103:1891 8. 3. Abramowitz Y, Jilaihawi H, Chakravarty T, et al. Mitral annulus calcifica- tion. J Am Coll Cardiol. 2015;66:1934 41. 4. Sud K, Agarwal S, Parashar A, et al. Degenerative mitral stenosis: unmet need for percutaneous interventions. Circulation. 2016;133:1594 604. 5. Bertrand PB, Mihos CG, Yucel E. Mitral annular calcification and calcific mitral stenosis: therapeutic challenges and considerations. Curr Treat Op- tions Cardiovasc Med. 2019;21:19. 6.1. Stages of MS 1. Baumgartner H, Hung J, Bermejo J, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Eur J Echocardiogr. 2009;10:1 25. 6.2. Rheumatic MS 6.2.1. Diagnosis and Follow-Up of Rheumatic MS 6.2.1.1. Diagnostic Testing: Initial Diagnosis 1. Baumgartner H, Hung J, Bermejo J, et al. 